L E Boyle - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

L E Boyle

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Journal of Lipid Research|January 1, 1990

An HPLC procedure for separating polyphosphoinositides on hydroxylapatiteL E Boyle, L A Sklar, A E Traynor-Kaplan

The Journal of Urology|May 1, 1978

Lymphangiography in patients with malignancy in a non-descended testicleK Jonsson, S Wallace, B S Jing, et al.

Cancer|January 1, 1977

Survival with inoperable lung cancer: an integration of prognostic variables based on simple clinical criteriaV J Lanzotti, D R Thomas, L E Boyle, et al.

Cancer Treatment Reports|January 1, 1976

Bleomycin (NSC-125066) followed by cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and 5-fllorouracil (NSC-19893) for non-oat cell bronchogenic carcinomaV J Lanzotti, D R Thomas, P Y Holoye, et al.

Pageof 1

Search research articles

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Journal of Lipid Research|January 1, 1990

An HPLC procedure for separating polyphosphoinositides on hydroxylapatiteL E Boyle, L A Sklar, A E Traynor-Kaplan

The Journal of Urology|May 1, 1978

Lymphangiography in patients with malignancy in a non-descended testicleK Jonsson, S Wallace, B S Jing, et al.

Cancer|January 1, 1977

Survival with inoperable lung cancer: an integration of prognostic variables based on simple clinical criteriaV J Lanzotti, D R Thomas, L E Boyle, et al.

Cancer Treatment Reports|January 1, 1976

Bleomycin (NSC-125066) followed by cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and 5-fllorouracil (NSC-19893) for non-oat cell bronchogenic carcinomaV J Lanzotti, D R Thomas, P Y Holoye, et al.

Pageof 1